找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Application of Nanocarriers in Brain Delivery of Therapeutics; Amit Alexander Book 2024 The Editor(s) (if applicable) and The Author(s), u

[復(fù)制鏈接]
樓主: JOLT
41#
發(fā)表于 2025-3-28 15:49:48 | 只看該作者
42#
發(fā)表于 2025-3-28 22:18:43 | 只看該作者
In Vitro Cell Line Culture for Brain Research and Its Limitations,cell line models for brain research. These models encompass a wide array of neuronal and glial cell lines, primary cultures, and sophisticated systems that closely mimic the brain’s intricate microenvironments. They have become invaluable tools for investigating various facets of brain biology and p
43#
發(fā)表于 2025-3-29 00:22:03 | 只看該作者
44#
發(fā)表于 2025-3-29 06:57:11 | 只看該作者
Safety, Stability Concerns, and Regulatory Aspects of Nanocarriers for Brain Delivery,he nanocarriers derived from metals, polymers, and other materials have shown their therapeutic efficacy against several neurological disorders during in vitro and preclinical studies. However, these nanocarriers, especially metal and silica NPs, have shown their toxicity against neuronal cell lines
45#
發(fā)表于 2025-3-29 10:42:33 | 只看該作者
Current Clinical Advancements of Nanocarriers for Brain Targeting and Limitations in Clinical Trans drug targeting, minimized side effects, improved drug efficiency, and patient compliance, nanocarriers take upper hand. Successful translation of research hypothesis led to clinical availability of a good number of nanomedicines intended for a range of physiological conditions like kidney dysfuncti
46#
發(fā)表于 2025-3-29 14:51:48 | 只看該作者
Application of Nanocarriers in Brain Delivery of Therapeutics
47#
發(fā)表于 2025-3-29 17:04:33 | 只看該作者
Application of Nanocarriers in Brain Delivery of Therapeutics978-981-97-2859-6
48#
發(fā)表于 2025-3-29 23:45:44 | 只看該作者
49#
發(fā)表于 2025-3-30 00:11:25 | 只看該作者
50#
發(fā)表于 2025-3-30 07:21:13 | 只看該作者
https://doi.org/10.1007/978-94-015-8175-2n disorders. However, bioactives have low bioavailability, poor solubility, and inefficient delivery because of blood-central nervous system barriers. To overcome these issues, a lipid nanocarrier system was found to be a suitable strategy for delivering these bioactives. This chapter discusses lipo
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 11:23
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
铁岭县| 鹤庆县| 南召县| 石棉县| 神池县| 白朗县| 宝应县| 邳州市| 高邮市| 无锡市| 睢宁县| 信阳市| 新和县| 肃宁县| 无棣县| 枣庄市| 宿迁市| 黎城县| 尉犁县| 当涂县| 克拉玛依市| 万盛区| 渑池县| 禹城市| 三江| 建始县| 香格里拉县| 浪卡子县| 广汉市| 台湾省| 牡丹江市| 资源县| 德安县| 襄樊市| 大理市| 阿克| 资阳市| 台前县| 舞钢市| 惠州市| 玉林市|